UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
JURIKA WILLIAM K C/O QUADRAMED CORPORATION 12110 SUNSET HILLS ROAD, SUITE 600 RESTON, VA 20190 |
 X |  |  |  |
/s/ Kelly G. Howard as Attorney in Fact for William K. Jurika | 12/18/2009 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | By the William K. Jurika IRA |
(2) | The Counterpoint Fund, L.P. sold its QuadraMed shares in the following transactions, all prior to Mr. Jurika joining the Board of Directors: 2/24/2009: 3,277 common shares sold at a price of $5.985; 2/25/2009: 6,400 common shares sold at a price of $5.979; 2/26/2009 11,100 common shares sold at a price of $5.981; 2/28/2009 15,000 common shares sold at a price of $5.994. |
(3) | The Jurika Family Trust, U/A 1989 owns 48.1% of Counterpoint Fund L.P., which is managed by Jurika, Mills, & Keifer, LLC ("JMK"), with Mr. Jurika acting as the managing member of JMK. |
 Remarks: Explanatory Note:  This Amended Form 3 is being filed to amend and restate the original Form 3 as filed with the SEC on May 1, 2009 which reported a holding of 35,777 shares by Counterpoint Fund, L.P.  As set forth in Footnote 2 above, Counterpoint Fund, L.P. sold its position in QuadraMed prior to Mr. Jurika joining the Board of Directors of QuadraMed Corporation on April 29, 2009.  No indirectly owned shares by the Counterpoint Fund, L.P. should have been reported on Mr. Jurika's original Form 3.  No other amendments to the original Form 3 have been made. |